VDR and systemic sclerosis: VDR knockdown enhances fibroblast sensitivity to TGF-β1 in patients with systemic sclerosis, and activation of VDR with paricalcitol reduces the stimulatory effect of TGF-β1 on fibroblasts, and so inhibits collagen production and myofibroblast differentiation.